Germany
Japan
United Kingdom
China
Primary Antibodies
View as table Download
Rabbit anti-VEGFR (Phospho-Tyr951) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanVEGFR2 around the phosphorylation site of tyrosine 951 (K-D-YP-V-G). |
| Modifications | Phospho-specific |
BLK Rabbit Polyclonal Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This BLK antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human BLK. |
Rabbit polyclonal RIPK2 (Ser176) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human RIPK2 around the phosphorylation site of serine 176 (S-L-SP-Q-S). |
| Modifications | Phospho-specific |
Rabbit polyclonal TGFBR2 (Ab-250) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human TGFBR2 around the phosphorylation site of serine 250 (D-R-SP-D-I). |
Rabbit polyclonal CaMKII (Thr305) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human CaMKII around the phosphorylation site of threonine 305 (I-L-TP-T-M). |
| Modifications | Phospho-specific |
Rabbit Polyclonal Antibody against MAP3K5 (S83)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This ASK1(MEKK5/MAP3K5) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 61-90 amino acids from human ASK1(MEKK5/MAP3K5). |
Rabbit polyclonal CDK5 (Ab-15) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human CDK5 around the phosphorylation site of tyrosine 15 (G-T-YP-G-T) |
Rabbit polyclonal MAP2K7 (Ser271) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human MAP2K7 around the phosphorylation site of serine 271 (V-D-SP-K-A). |
| Modifications | Phospho-specific |
Rabbit polyclonal ETK / BMX(Ab-566) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human ETK around the phosphorylation site of tyrosine 566 (D-Q-YP-V-S). |
PIM1 Antibody (C-term ) Rabbit Polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This PIM1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 374-404 amino acids from the C-terminal region of human PIM1. |
Rabbit Polyclonal Antibody against BRAF (Center)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This B-RAF antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 424-453 amino acids from the Central region of human B-RAF. |
Rabbit polyclonal CSFR (Ab-809) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human CSFR around the phosphorylation site of tyrosine 809 (S-N-YP-I-V). |
Rabbit polyclonal p38 MAPK (Ab-322) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human p38 MAPK around the phosphorylation site of tyreonine 322 (D-P-Y-D-Q). |
Rabbit Polyclonal Antibody against DDR1 (Center)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This DDR1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 299-330 amino acids from the Central region of human DDR1. |
Rabbit Polyclonal Antibody against AKT2 (N-term)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This AKT2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 93-123 amino acids from the N-terminal region of human AKT2. |
Rabbit Polyclonal antibody to FAST (Fas-activated serine/threonine kinase)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment corresponding to a region within amino acids 346 and 549 of FAST (Uniprot ID#Q14296) |
Active filters
Applications
- IHC
Antibody Hosts
- Rabbit
Families
- Protein Kinase
Availabilities
- In Stock
Filter by
Category
Target Symbol
- AKT1 (8)
- PAK1 (7)
- BRAF (5)
- ERBB3 (4)
- GSK3A (4)
- MAP2K4 (4)
- MAP2K6 (4)
- MTOR (4)
- NTRK1 (4)
- RAF1 (4)
- RPS6KB1 (4)
- SRC (4)
- AATK (3)
- ACVR1C (3)
- AKT2 (3)
- ALK (3)
- BMX (3)
- CAMK2B (3)
- CDK5 (3)
- CSNK1A1 (3)
- EIF2AK3 (3)
- FGFR2 (3)
- LATS1 (3)
- MAP3K4 (3)
- MAP3K8 (3)
- PAK2 (3)
- PAK5 (3)
- PRKCA (3)
- PRKD1 (3)
- RPS6KA1 (3)
- TNK2 (3)
- TRPM7 (3)
- ACVR1B (2)
- ADCK1 (2)
- AKT3 (2)
- BLK (2)
- BMPR2 (2)
- CHUK (2)
- COQ8B (2)
- CSF1R (2)
- CSNK1E (2)
- CSNK2A1 (2)
- DCLK3 (2)
- EPHB6 (2)
- ERBB2 (2)
- FASTK (2)
- FGFR3 (2)
- FRK (2)
- GRK1 (2)
- ILK (2)
- JAK1 (2)
- LIMK2 (2)
- MAP2K1 (2)
- MAP3K12 (2)
- MAP3K5 (2)
- MAP3K7 (2)
- MAP4K1 (2)
- MAP4K5 (2)
- MAPK14 (2)
- MAPK8 (2)
- MAPKAPK2 (2)
- MARK1 (2)
- MERTK (2)
- NTRK2 (2)
- PDK4 (2)
- PIM1 (2)
- PLK1 (2)
- PRKAA2 (2)
- PRKACG (2)
- PRKCD (2)
- PRKCQ (2)
- PRKX (2)
- RET (2)
- RIPK2 (2)
- ROCK1 (2)
- ROR1 (2)
- RPS6KA5 (2)
- RPS6KA6 (2)
- SGK1 (2)
- SIK1 (2)
- STK11 (2)
- STK17B (2)
- STK36 (2)
- STK39 (2)
- STRADB (2)
- TEK (2)
- TGFBR1 (2)
- TGFBR2 (2)
- TRIM24 (2)
- WNK3 (2)
- ABL1 (1)
- ABL2 (1)
- ACVR1 (1)
- ACVR2A (1)
- ACVRL1 (1)
- ALPK2 (1)
- AURKC (1)
- BCR (1)
- BRD4 (1)
- BTK (1)
Reactivities
Clonalities
Conjugates
Modifications
Pathways
- MAPK signaling pathway (127)
- ErbB signaling pathway (80)
- Pathways in cancer (80)
- Neurotrophin signaling pathway (70)
- Focal adhesion (66)
- Chemokine signaling pathway (60)
- T cell receptor signaling pathway (56)
- GnRH signaling pathway (52)
- Insulin signaling pathway (51)
- Progesterone-mediated oocyte maturation (51)
- Fc epsilon RI signaling pathway (50)
- Pancreatic cancer (46)
- Toll-like receptor signaling pathway (46)
- Fc gamma R-mediated phagocytosis (45)
- Acute myeloid leukemia (43)
- Colorectal cancer (42)
- Prostate cancer (42)
- Regulation of actin cytoskeleton (42)
- Chronic myeloid leukemia (41)
- Glioma (41)
- Renal cell carcinoma (41)
- VEGF signaling pathway (39)
- mTOR signaling pathway (39)
- Axon guidance (37)
- Endocytosis (37)
- Non-small cell lung cancer (33)
- Adipocytokine signaling pathway (32)
- Long-term potentiation (32)
- Vascular smooth muscle contraction (32)
- Wnt signaling pathway (32)
- Endometrial cancer (31)
- Melanoma (31)
- Epithelial cell signaling in Helicobacter pylori infection (30)
- Tight junction (29)
- Apoptosis (28)
- B cell receptor signaling pathway (28)
- Gap junction (27)
- Natural killer cell mediated cytotoxicity (27)
- Adherens junction (26)
- Oocyte meiosis (26)
- Calcium signaling pathway (24)
- Melanogenesis (23)
- TGF-beta signaling pathway (23)
- Long-term depression (20)
- Bladder cancer (19)
- Cytokine-cytokine receptor interaction (18)
- Jak-STAT signaling pathway (18)
- Small cell lung cancer (18)
- NOD-like receptor signaling pathway (17)
- RIG-I-like receptor signaling pathway (16)
- Leukocyte transendothelial migration (15)
- Thyroid cancer (15)
- Hedgehog signaling pathway (14)
- Type II diabetes mellitus (13)
- Amyotrophic lateral sclerosis (ALS) (12)
- Cell cycle (12)
- Olfactory transduction (12)
- Prion diseases (10)
- Vibrio cholerae infection (9)
- Alzheimer's disease (8)
- Pathogenic Escherichia coli infection (8)
- Dilated cardiomyopathy (5)
- Taste transduction (5)
- Cytosolic DNA-sensing pathway (4)
- Hematopoietic cell lineage (4)
- Phosphatidylinositol signaling system (4)
- Regulation of autophagy (4)
- Basal cell carcinoma (3)
- Dorso-ventral axis formation (3)
- Hypertrophic cardiomyopathy (HCM) (3)
- Viral myocarditis (3)
- p53 signaling pathway (3)
- Circadian rhythm - mammal (2)
- PPAR signaling pathway (2)
- Purine metabolism (2)
- Basal transcription factors (1)
- Non-homologous end-joining (1)
- Parkinson's disease (1)
- Primary immunodeficiency (1)
- Ubiquitin mediated proteolysis (1)